Genetic variants in CDC42 and NXPH1 as susceptibility factors for constipation and diarrhoea predominant irritable bowel syndrome

Mira M. Wouters, Diether Lambrechts, Michael Knapp, Isabelle Cleynen, Peter Whorwell, Lars Agréus, Aldona Dlugosz, Peter Thelin Schmidt, Jonas Halfvarson, Magnus Simrén, Bodil Ohlsson, Pontus Karling, Sander Van Wanrooy, Stéphanie Mondelaers, Severine Vermeire, Greger Lindberg, Robin Spiller, George Dukes, Mauro D'Amato, Guy Boeckxstaens

    Research output: Contribution to journalArticlepeer-review

    Abstract

    Objective: The complex genetic aetiology underlying irritable bowel syndrome (IBS) needs to be assessed in large-scale genetic studies. Two independent IBS cohorts were genotyped to assess whether genetic variability in immune, neuronal and barrier integrity genes is associated with IBS. Design: 384 single nucleotide polymorphisms (SNPs) covering 270 genes were genotyped in an exploratory cohort (935 IBS patients, 639 controls). 33 SNPs with P uncorrected
    Original languageEnglish
    Pages (from-to)1103-1111
    Number of pages8
    JournalGut
    Volume63
    Issue number7
    DOIs
    Publication statusPublished - 2014

    Keywords

    • GENETIC POLYMORPHISMS
    • IMMUNE RESPONSE

    Fingerprint

    Dive into the research topics of 'Genetic variants in CDC42 and NXPH1 as susceptibility factors for constipation and diarrhoea predominant irritable bowel syndrome'. Together they form a unique fingerprint.

    Cite this